Phibro Animal Health (NASDAQ:PAHC) Given New $21.00 Price Target at Morgan Stanley

Phibro Animal Health (NASDAQ:PAHC) had its target price lifted by Morgan Stanley from $20.00 to $21.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

A number of other equities analysts have also recently commented on PAHC. StockNews.com cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. Barclays boosted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $20.00.

Phibro Animal Health Trading Up 1.0 %

Shares of NASDAQ PAHC opened at $22.48 on Thursday. Phibro Animal Health has a 1-year low of $16.16 and a 1-year high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The business’s 50 day moving average is $19.99 and its two-hundred day moving average is $21.84. The stock has a market capitalization of $910.51 million, a P/E ratio of 46.83, a PEG ratio of 0.45 and a beta of 0.62.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, research analysts expect that Phibro Animal Health will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. bought a new position in Phibro Animal Health in the fourth quarter worth approximately $29,000. Lazard Asset Management LLC increased its holdings in shares of Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock valued at $34,000 after purchasing an additional 1,589 shares during the period. Aquatic Capital Management LLC purchased a new position in Phibro Animal Health during the 4th quarter worth approximately $69,000. Virtus Fund Advisers LLC acquired a new position in Phibro Animal Health during the fourth quarter valued at $69,000. Finally, Quantbot Technologies LP boosted its stake in shares of Phibro Animal Health by 65.1% in the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company’s stock worth $107,000 after buying an additional 2,018 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.